-
protein subunit COVID-19
vaccine candidate developed by a
subsidiary of
Livzon Pharmaceutical Group Inc. A
preclinical study in
rhesus macaques was published...
- jinlugroup.cn 000513
Livzon Group 丽珠集团
Livzon Pharmaceutical Group Inc. 28.10.1993 614,898,458 595,686,107
Manufacturing http://www.
livzon.com.cn 000514 YUKAIFA...
- (0)
Emergency (1)
India V-01 is a
protein subunit vaccine developed by
Livzon Mabpharm. Full (0)
Emergency (1)
China IndoVac is a
protein subunit vaccine...
- drugs.
Leading enterprises such as
Guangzhou Baiyunshan Pharmaceutical,
Livzon Pharmaceutical Group,
United Laboratories Internet,
Bright ****ure have settled...
- I (168)
Phase II (420)
Phase I/II (320) Jun 2020 – Oct 2021,
China V-01
Livzon Mabpharm, Inc.
China Subunit (SARS-CoV-2
recombinant fusion protein) Phase...
-
equipment from two
Chinese companies Guangzhou Wondfo Biotech and
Zhuhai Livzon Diagnostics due to
their unsatisfactory performance. In response, Chinese...
-
Medical Textile Ariegeois. 2020 6 July 2020 L&R
entered a
partnership with
Livzon Pharma Enters into
Licensing Agreement with
Lohmann Therapie-Systeme. 2021...
-
third in
Guangdong province for years. The main
enterprises are:
Zhuhai Livzon Pharmaceutical Group Limited by
Share Ltd (丽珠集团),
Zhuhai Federal Pharmaceutical...
